PHILADELPHIA – Women who want to quit smoking may have better success by carefully timing their quit date with optimal days within their menstrual cycle, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The results, published online this month in Biology of Sex Differences, were also presented at the annual meeting of the Organization for the Study of Sex Differences (OSSD), held at Penn.
Cigarette smoking remains the leading cause of preventable death in the United States, and women experience more severe health consequences from cigarette smoking than men, including a 25 percent increased risk of developing coronary heart disease and chronic obstructive pulmonary disease. Research also shows that women have greater difficulty with smoking cessation than men.
“Understanding how menstrual cycle phase affects neural processes, cognition and behavior is a critical step in developing more effective treatments and in selecting the best, most individualized treatment options to help each cigarette smoker quit,” said the study’s lead author, Reagan Wetherill, PhD, a research assistant professor of Psychology.
Wetherill and senior author Teresa Franklin, PhD, a research associate professor of Neuroscience in Psychiatry, have been studying the brains of premenopausal women who smoke cigarettes for several years in Penn’s Center for the Studies of Addiction. Their work is based on a significant animal literature showing that the natural sex hormones -- estrogen and progesterone -- which fluctuate over the course of the menstrual cycle modulate addictive behavior. The animal data show that during the pre-ovulatory, or follicular phase of the menstrual cycle, when the progesterone-to-estrogen ratio is low, women are more likely to be spurred toward addictive behaviors. Alternatively, during the early pre-menstrual or luteal phase of the menstrual cycle, when the progesterone-to-estrogen ratio is high, addictive behaviors are thwarted, suggesting that progesterone might protect women from relapsing to smoking.
In the current study, 38 physically healthy, premenopausal women who smoke and who were not taking hormonal contraceptives, ranging from 21 to 51 years of age, received a functional MRI scan to examine how regions of the brain that help control behavior are functionally connected to regions of the brain that signal reward.
The researchers theorized that the natural fluctuations in ovarian hormones that occur over the course of the monthly menstrual cycle affect how women make decisions regarding reward – smoking a cigarette -- and so-called “smoking cues,” which are the people, places and things that they associate with smoking, such as the smell of a lit cigarette or going on their coffee break. These “appetitive reminders” to smoke are perceived as pleasant and wanted, and similar to cigarettes, are also rewarding.
In 2015, the researchers showed that compared to when women are in the luteal phase of their menstrual cycle, which is the period of time following ovulation and prior to menstruation, women in the follicular phase – which begins at menstruation and continues until ovulation – have enhanced responses to smoking cues in reward-related brain regions. This finding led them to further test whether groups differed in the strength of the functional connections that exists between regions exerting cognitive control and reward-related brain regions. The weaker the functional connections between cognitive control brain regions and reward signaling brain regions, the less ability women have to ‘Just Say No’ when attempting to quit.
The women in the study were separated into two groups – those in their follicular phase and those in their luteal phase. Results revealed that during the follicular phase, there was reduced functional connectivity between brain regions that helps make good decisions (cortical control regions) and the brain regions that contain the reward center (ventral striatum), which could place women in the follicular phase at greater risk for continued smoking and relapse. Orienting attention towards smoking cues (pictures of smoking reminders such as an individual smoking) was also shown to be associated weaker connections between cognitive control regions in follicular females.
“These data support existing animal data and an emerging human literature showing that progesterone may exert protective effects over addictive behavior and importantly, the findings provide new insights into sex differences in smoking behavior and relapse,” Franklin said. “Interestingly, the findings may represent a fundamental effect of menstrual cycle phase on brain connectivity and may be generalizable to other behaviors, such as responses to other rewarding substances (i.e., alcohol and foods high in fat and sugar).
“The results from this study become extremely important as we look for more ways to help the over 40 million individuals in the U.S. alone addicted to cigarettes,” Franklin, continued. “When we learn that something as simple as timing a quit date may impact a woman’s cessation success, it helps us to provide more individualized treatment strategies for individuals who are struggling with addiction.”
Additional Penn authors include Kanchana Jagannathan, Nathan Hager and Melanie Maron.
Funding for the study was provided by National Institute of Health (P60-DA-005186-18, R21DA025882, R01DA030394, R01DA029845, K23AA02389), and Pfizer Pharma.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.